Relation

📍 London, United Kingdom🗓 Founded 2019👥 126 employees💰 Last funded Mar 2024
Biotechnology Research🌐 relationrx.com
Website LinkedIn
We are an end-to-end biotech developing transformational medicines, with technology at our core. Our ambition is to understand human biology in an unprecedented way; discovering therapies that will treat some of lifes most devastating diseases. We leverage single-cell and multi-omics measurements directly from patient tissue, functional assays and machine learning to drive disease understanding — from cause to cure. Medicines born from high-resolution biology, machine learning and clinical insights. Our Lab-in-the-Loop seamlessly integrates single-cell analysis, genomics and machine learning. We have developed powerful technologies which we apply to select druggable targets and develop transformational medicines.
6
Total investors
4
Early stage
2
Mid stage
0
Late stage
2019
Founded

Investors

6 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
United States
4
United Kingdom
2
Investor activity2021–2024 · investors recorded per year
202142022120241
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Relation?
Relation has 6 investors on record on gritt.io, including 4 early-stage backers, 2 mid-stage.
When did Relation last raise funding?
The most recent investment in Relation recorded on gritt.io was in March 2024.
When was Relation founded?
Relation was founded in 2019.
What industry is Relation in?
Relation operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Relation based?
Relation is headquartered in London, United Kingdom.